Image For Activity Cover
ITLPEDUC2203 - CME/CMLE - Ki67 as a Prognostic and Predictive Biomarker in HR-PositiveHER2-Negative Early Breast Cancer
Course Description

Faculty/Authors

Aysegul Sahin, MD - Professor of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA 
Ali Brown, MD, FASCP - American Society for Clinical Pathology, Chicago, IL, USA 
Erin Downs-Kelly, DO - Cleveland Clinic, Cleveland, OH USA 



CME/CMLE Credit: 0.75 
Estimated Completion Time: 0.75 hour
Format: Online Educational Activity

Physician Competencies: Patient Care, Medical Knowledge  

Accreditation Statement:
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Review the Faculty Disclosures.
  3. Click Go to Course to view an overview of the modules in this course.
  4. Click Access to begin the course.
  5. Review the Educational Activity.
  6. Submit the course Evaluation.
  7. Enter the maximum number of credits offered and click Claim CME to register credit.

Faculty Disclosure

Technical Considerations

Release Date: 2/28/22  
Review Date:
Expiration Date: 2/28/25  

Summary
Availability: On-Demand
Credit Offered:
0.75 CME/CMLE Credit
Powered By